Pennathur Arjun, Abbas Ghulam, Gooding William E, Schuchert Matthew J, Gilbert Sebastien, Christie Neil A, Landreneau Rodney J, Luketich James D
Heart, Lung, and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA.
Ann Thorac Surg. 2009 Nov;88(5):1601-6; discussion 1607-8. doi: 10.1016/j.athoracsur.2009.05.012.
Surgical resection is the standard of care for patients with resectable non-small cell lung cancer or selected patients with pulmonary metastases. However, for high-risk patients radiofrequency ablation (RFA) may offer an alternative option. The objective of this study was to evaluate computed tomography-guided RFA for high-risk patients and report our initial experience in 100 consecutive patients by a thoracic surgical service.
Medically inoperable patients were offered RFA. Thoracic surgeons evaluated and performed RFA under computed tomography guidance. Patients were followed in the thoracic surgery clinic. The primary end point evaluated was overall survival.
One hundred patients underwent image-guided RFA for lung neoplasm (40 men, 60 women; median age, 73.5 years; range, 26 to 95 years). Forty-six patients (46%) with primary lung neoplasm, 25 patients (25%) with recurrent cancer, and 29 patients (29%) with pulmonary metastases underwent RFA. The mean follow-up for alive patients was 17 months. The median overall survival for the entire group of patients was 23 months. The probabilities of 2-year overall survival for the entire group, primary lung cancer patients, recurrent cancer patients, and metastatic cancer patients were 49% (95% confidence interval, 37 to 60), 50% (95% confidence interval, 33 to 65), 55% (95% confidence interval, 25 to 77), and 41% (95% confidence interval, 19 to 62), respectively.
Our experience indicates that image-guided RFA done by the thoracic surgeons is feasible and safe in high-risk patients with lung neoplasm with reasonable results in patients who are not fit for surgery. Thoracic surgeons can perform RFA safely, and should continue to investigate this new image-guided modality that may offer an alternative option in medically inoperable patients.
手术切除是可切除的非小细胞肺癌患者或部分肺转移患者的标准治疗方法。然而,对于高危患者,射频消融(RFA)可能提供另一种选择。本研究的目的是评估计算机断层扫描引导下的RFA在高危患者中的应用,并报告胸外科连续100例患者的初步经验。
为医学上无法手术的患者提供RFA。胸外科医生在计算机断层扫描引导下进行评估和RFA操作。患者在胸外科门诊接受随访。评估的主要终点是总生存期。
100例患者接受了影像引导下的肺部肿瘤RFA治疗(男性40例,女性60例;中位年龄73.5岁;范围26至95岁)。46例(46%)原发性肺部肿瘤患者、25例(25%)复发性癌症患者和29例(29%)肺转移患者接受了RFA治疗。存活患者的平均随访时间为17个月。整个患者组的中位总生存期为23个月。整个组、原发性肺癌患者、复发性癌症患者和转移性癌症患者的2年总生存概率分别为49%(95%置信区间,37至60)、50%(95%置信区间,33至65)、55%(95%置信区间,25至77)和41%(95%置信区间,19至62)。
我们的经验表明,胸外科医生进行的影像引导下RFA在高危肺部肿瘤患者中是可行且安全的,对于不适合手术的患者有合理的结果。胸外科医生可以安全地进行RFA,并且应该继续研究这种新的影像引导方式,它可能为医学上无法手术的患者提供另一种选择。